PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, VA 20110, USA.\', \'Public Health Research Institute, Rutgers, New Jersey Medical School, the State University of New Jersey, Newark, NJ 07103, USA.\', \'Innovation Pharmaceuticals Inc., Wakefield, MA 01880, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 27110.3390/v13020271
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 33572467
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
?:title
  • Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all